Skip navigation

no spam, unsubscribe anytime.
Skip navigation
Goal: 30,000 Progress: 1,617
Sponsored by: The Alzheimer's Site

In 2015, America was outraged as the cost of a little-known drug called Daraprim skyrocketed overnight from $13.50 to $750 a pill. In 2016, the ubiquitous allergy medicine Epi-Pen rose from $100 to $600 in an instant.

Why? Profit.

These scandals are just two examples of a pervasive problem with American healthcare, which allows pharmaceutical companies to set prices as they see fit with a patchwork system of insurance providers. There are no restrictions of profit margins. There is little transparency in the pricing process. The result? Americans pay more for prescription drugs than any other nation in the world.

In most European countries, single-payer health systems use their size to negotiate big discounts, but the United States does not have a similar program and Obamacare did nothing to rein in the costs of prescription drugs when it was passed.

Clearly, something needs to change. When the price of lifesaving drugs suddenly goes from affordable to exorbitant, people deserve to understand why. When the VA is allowed to negotiate directly with drug companies, but Medicare is not, Medicare ends up with a deal that's better for the pharmaceutical companies than the people Medicare serves.

Two changes to current American policy would go a long way to ensuring pharmaceutical companies don't exploit the sick:

  1. Require drug-makers to justify the costs of their treatments and disclose major price hikes.
  2. Repeal the noninterference clause of the Medicare Modernization Act of 2003 which prevents Medicare, the single largest payer for health care in the U.S., from negotiating directly with drug companies.

Tell the Department of Health and Human Services enact the above legislation which would be a good start to controlling out-of-control drug prices in the United States. The American public shouldn't be expected to pad the pocketbooks of wealthy pharmaceutical executives! Lives are on the line.

Sign Here






To the Secretary of Health and Human Services,

I am writing to you to express my concern for the growing cost of prescription drugs in the United States. Pharmaceutical companies are taking advantage of ordinary, sick Americans, and it's up to you to do something about it.

Over the past few years, from Daraprim to EpiPen, we have seen a series of scandals emerge as pharmaceutical companies increase the prices of old drugs in an attempt to increase profits year after year. Since the United States has no single-payer healthcare system, this means the American public is being asked to shoulder the burden of these companies limitless greed at the cost of their health and financial stability.

Clearly, something needs to change. When the price of lifesaving drugs suddenly goes from affordable to exorbitant, people deserve to understand why. When the VA is allowed to negotiate directly with drug companies, but Medicare is not, Medicare ends up with a deal that's better for the pharmaceutical companies than the people Medicare serves.

Two changes to current American policy would go a long way to ensuring pharmaceutical companies don't exploit the sick:

  1. Require drug-makers to justify the costs of their treatments and disclose major price hikes.
  2. Repeal the noninterference clause of the Medicare Modernization Act of 2003 which prevents Medicare, the single largest payer for health care in the U.S., from negotiating directly with drug companies.

Please, enact the above policies which would be a good start to controlling out-of-control drug prices in the United States. The American public shouldn't be expected to pad the pocketbooks of wealthy pharmaceutical executives.

Petition Signatures


Feb 20, 2018 Susan Closson
Feb 20, 2018 Ginger Gorum
Feb 20, 2018 Donald DavisSr
Feb 20, 2018 Joyce Davis
Feb 20, 2018 Aly Jones
Feb 20, 2018 Jill Madden
Feb 20, 2018 Ann Morris
Feb 20, 2018 Kendra Sterken
Feb 20, 2018 (Name not displayed)
Feb 20, 2018 (Name not displayed)
Feb 20, 2018 Tobey Thatcher
Feb 20, 2018 Randi Mayrent
Feb 20, 2018 Mary Delger
Feb 20, 2018 Lisa Wojciechowski
Feb 20, 2018 (Name not displayed) People before Profits!
Feb 20, 2018 Angela Ramirez
Feb 20, 2018 Ruth Rogers
Feb 20, 2018 Nellie Owen
Feb 20, 2018 Debra Rortina
Feb 20, 2018 Derek Bennett
Feb 20, 2018 Rosemary Bennett
Feb 20, 2018 (Name not displayed)
Feb 20, 2018 (Name not displayed) This is a serious problem and we elect people to help not make things worse, so do your job.
Feb 20, 2018 Rita Baker
Feb 20, 2018 Aine O'Neill
Feb 20, 2018 Mark Warren
Feb 20, 2018 Karen Deckel
Feb 20, 2018 Lesli Cetrulo Id say something about the people who make the dicisions on these prices, but the only get off on these comments
Feb 5, 2018 Cara Schmidt
Feb 5, 2018 Kimberley Clack
Feb 5, 2018 Russell Jackson
Jan 30, 2018 Thomas Re'
Jan 29, 2018 (Name not displayed) Can you please sign this too?
Jan 29, 2018 Orva M Gullett
Jan 28, 2018 Janis Westendorf
Jan 26, 2018 Jodi Ford
Jan 25, 2018 june harty
Jan 21, 2018 Steve Luongo
Jan 18, 2018 Dorothee Mulhausen
Jan 18, 2018 (Name not displayed) Maybe if pharmaceutical companies weren’t in the back pockets of the members of the FDA, DEA and Congress, this wouldn’t be as serious of a problem.
Jan 18, 2018 Suzanne Danielson
Jan 18, 2018 Nancy Lopez Maybe what we need is an FDA that is not a wholly-owned subsidiary of big pharma
Jan 18, 2018 Nanette Silva
Jan 18, 2018 Catherine Stevens
Jan 16, 2018 jennifer leagan
Jan 16, 2018 Susan Jenkins
Jan 16, 2018 Didi Summerhawk
Jan 15, 2018 (Name not displayed)
Jan 14, 2018 Sieglinda Preez
Jan 13, 2018 Beverly Brzycki

back to top

Beaded Beauty Sleeveless Tunic
Savings Spree
Share this page and help fund research: